HHR launched Haramaya University’s first-ever clinical trial, ECHiLiBRiST (Enhancing Children’s Life using Biomarkers for Risk Stratification and Triage), at Hiwot Fana Comprehensive Specialized Hospital. The study is designed to scientifically identify the causes of child mortality and provide evidence -driven policy inputs to develop effective solutions. This groundbreaking clinical trial aims to revolutionize pediatric care by using advanced biomarkers to better identify and prioritize at-risk children.
This research initiative is funded by Horizon Europe and is led globally in collaboration with the Barcelona Institute for Global Health (ISGlobal).
In his opening remarks, Dr. Jemal Yousuf, President of Haramaya University, stated that launching this first clinical trial is a defining milestone in the university’s scientific journey and advancement of evidence-based healthcare in Ethiopia. He emphasized that by providing evidence-based data, the trial will significantly contribute to the success of national efforts to reduce child mortality in Ethiopia.
Dr. Jemal noted that starting this clinical trial research on pediatric fever is a transformative step toward strengthening the university’s contributions in informing national health policy and improving the lives of the community. He added that launching this clinical trial is not only a scientific advancement but also the undertaking of a profound ethical commitment, ensuring integrity and honoring the dignity and safety of the children, families, and community participating in the study.
Prof. Nega Assefa, HHR Lead and Clinical Trial Principal Investigator, noted that since its establishment in 2017, HHR has gained international recognition for its work in improving the health sector. He revealed that preparations for this clinical trial have been underway for the past two years, successfully passing rigorous assessments by relevant regulatory bodies to reach the launch stage.
Dr. Lola Madrid, the Global Principal Investigator of ECHiLiBRiST, stated that the research follows both international and national research guidelines. It is a collaboration led by 13 international research institutions and experts across Africa, Europe, and North America. She added that the project aims to strengthen systems for the rapid identification and treatment of children arriving at hospitals with fever, contributing significantly to efforts to prevent diseases that are currently leading causes of child mortality.
Dr. Abdi Amin, Head of the Harari Regional Health Bureau, emphasized that evidence-based research is essential to sustaining improvements in the health sector. He noted that this clinical trial will serve as a major resource for similar future research and confirmed that the Regional Health Bureau will provide all necessary support for the initiative.
